Repurposing Alkylating Agents in Melanoma via ERCC8 Silencing: A Novel Therapeutic Strategy

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC12939398 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature